Evidence has been increasingly provided that lipid accumulation in kidney contributes to the progression of chronic kidney disease (CKD).^[@bib1],\ [@bib2]^ Receptor-mediated lipid uptake is the crucial step for lipid retention in the kidney, while this is also caused by impaired cholesterol synthesis and inhibited cholesterol efflux via adenosine triphosphate-binding cassette transporter 1.^[@bib3],\ [@bib4],\ [@bib5],\ [@bib6],\ [@bib7],\ [@bib8],\ [@bib9]^ Several lines of data have indicated that the specific transmembrane receptors, including scavenger receptor A (SR-A), CD36, lectin-like oxidized low-density lipoprotein receptor-1, and C-X-C motif ligand 16, recognize oxidative low-density lipoprotein (ox-LDL) based on atherogenesis data.^[@bib5],\ [@bib6],\ [@bib7],\ [@bib8],\ [@bib9]^ Among these receptors, SR-A has been identified on macrophages, endothelial cells, renal mesangial cells, smooth muscle cells, dendritic cells, and renal tubular epithelial cells.^[@bib6],\ [@bib10],\ [@bib11],\ [@bib12],\ [@bib13]^ Unlike other lipoprotein receptors, SR-A is not regulated via negative feedback by cytoplasmic cholesterol, and hence plays a key role in the formation of foam cells.^[@bib12],\ [@bib14]^

Previous studies have shown that deletion of SR-A decreased aortic wall plaque formation in mice fed with high-fat diet and had no impact on the plasma lipid level.^[@bib5],\ [@bib11],\ [@bib13]^ SR-A mediates endocytosis of ox-LDL, and activates intracellular signaling pathways that contribute to the atherosclerosis. Its mechanistic role in atherosclerosis elicited by hyperlipidemia may suggest possible mechanisms underlying the development of lipid-induced renal injury and enhance the design of novel therapeutic strategies against the progression of CKD. However, the effect of SR-A deficiency on the progressive CKD of hyperlipidemia and the underlying mechanism by which SR-A modulates renal fibrosis remains poorly understood.

Here, we use SR-A deficient (SR-A^−/−^) mice to test the hypothesis that its deficiency will protect kidney from lipid nephrotoxicity in progressive renal fibrosis. We identified SR-A as a key regulator in the renal lipid retention, CD11c^+^ cell recruitment, and oxidative stress in uninephrectomized mice following 16 weeks of high-fat diet. Using genetic approaches, we validated SR-A as a critical modulator of transforming growth factor (TGF)-β1/Smad signaling and monocyte chemoattractant protein-1 (MCP-1) in HK-2 cells exposed to ox-LDL *in vitro*. In bone marrow (BM) chimeric mice, SR-A^−/−^ to wild-type (WT) bone marrow transplantation (BMT) led to reduced albuminuria, renal CD11c^+^ cell filtration, and kidney fibrosis independent of plasma lipid control.

RESULTS
=======

SR-A deficiency ameliorated albuminuria and renal fibrosis in uninephrectomized mice fed with high-fat diet
-----------------------------------------------------------------------------------------------------------

All SR-A^−/−^ mice were verified by Southern blot, western blot, and immunohistochemistry ([Supplementary Figure S1a--c](#sup1){ref-type="supplementary-material"} online). No significant abnormalities in body weight, morphology, renal histology, and plasma biochemical parameters were found as long as 24 weeks of age between WT and SR-A^−/−^ mice ([Figure 1c and e](#fig1){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). To evaluate the effect of SR-A on the hyperlipidemic renal disease, WT and SR-A^−/−^ mice at 8 weeks of age underwent uninephrectomy, followed by either normal or high-fat diet for 16 weeks, following the way as described.^[@bib15]^ Both WT and SR-A^−/−^ mice that consumed high-fat diet showed markedly increased body weights and systemic lipid levels when compared with normal-diet mice ([Table 1](#tbl1){ref-type="table"}). There was no difference in plasma lipids between WT and SR-A^−/−^ mice in the conditions of either normal or high-fat diet, indicating that SR-A did not affect the systemic lipid levels.

Consistent with the previous studies,^[@bib1],\ [@bib2],\ [@bib16]^ our data showed that WT mice consuming high-fat diet developed progressive albuminuria; however, this was lower at 8 weeks, and significantly reduced at 16 weeks of dietary intervention in SR-A^−/−^ mice ([Figure 1a](#fig1){ref-type="fig"}). In addition, high-fat diet resulted in markedly reduced kidney weight/body weight in WT mice but was mild in SR-A^−/−^ mice ([Figure 1b](#fig1){ref-type="fig"}). Normal-diet WT and SR-A^−/−^ mice did not show remarkably increased albuminuria ([Figure 1a](#fig1){ref-type="fig"}). Morphologically, diet-induced hyperlipidemia caused significant glomerular mesangial matrix accumulation and tubulointerstitial fibrosis, but no remarkable microvascular damage in kidney was observed under light microscope. In contrast, SR-A deficiency substantially reduced glomerular mesangial matrix index and tubulointerstitium fibrotic area compared with those of WT mice with hyperlipidemia ([Figure 1c--f](#fig1){ref-type="fig"}). In addition, persistent hyperlipidemia markedly increased the renal deposition of fibronectin, collagen I, and collagen III in WT mice but was mild in SR-A^−/−^ mice ([Figure 2a--d](#fig2){ref-type="fig"}). Importantly, the improved renal outcome in SR-A^−/−^ mice was determined to be independent of hyperlipidemia, as diet-induced high plasma levels of cholesterol and triglyceride were similar in both mice genotypes ([Table 1](#tbl1){ref-type="table"}).

SR-A deficiency reduced renal lipid accumulation and oxidative stress in uninephrectomized mice fed with high-fat diet
----------------------------------------------------------------------------------------------------------------------

Using Oil Red O staining, we detected increased lipids retention in the kidneys of high-fat diet mice. SR-A deficiency markedly reduced the renal lipid deposition compared with WT mice consuming high-fat diet ([Figure 3a and b](#fig3){ref-type="fig"}), indicating that the ameliorated kidney fibrosis in SR-A^−/−^ mice was correlated with lower renal lipid deposition. Although the initial events involved in lipid-mediated renal damage are unclear, oxidative stress is thought to be especially important.^[@bib2],\ [@bib17]^ We revealed that mice consuming high-fat diet showed a threefold increase in renal reactive oxidative species (ROS), which was reduced in SR-A^−/−^ mice ([Figure 3c and d](#fig3){ref-type="fig"}). To link the decreased ROS production to lower lipid deposition in the kidneys, renal ROS and the cholesterol content were quantified in the mice described above. Our data showed that the mice with higher renal cholesterol content correlated with higher ROS production in the kidneys; in SR-A^−/−^ mice, renal ROS decreased with lower content of cholesterol ([Figure 3e](#fig3){ref-type="fig"}). Also, mice consuming high-fat diet showed a 3.5-fold increase in renal malondialdehyde, a biomarker for oxidative stress,^[@bib18]^ which was significantly reduced in SR-A^−/−^ mice ([Figure 3f](#fig3){ref-type="fig"}). Thus, these data suggested that SR-A deficiency decreased renal cholesterol deposition and, consequently, reduced oxidative stress in lipid-induced kidney injury.

SR-A deficiency decreased renal CD11c^+^ cell filtration and inflammation in uninephrectomized mice fed with high-fat diet
--------------------------------------------------------------------------------------------------------------------------

One detrimental effect of oxidative stress is to cause inflammation in the progressive kidney disease.^[@bib2],\ [@bib4],\ [@bib8]^ To test the effect of SR-A deficiency on inflammatory profile in response to hyperlipidemia, mice plasma inflammatory markers were examined. There was a twofold increase in plasma tumor necrosis factor (TNF)-α and a fourfold increase in interleukin (IL)-6 in WT mice consuming high-fat diet compared with those of normal diet; in contrast, SR-A deficiency markedly reduced plasma levels of TNF-α and IL-6 ([Table 1](#tbl1){ref-type="table"}).

Recent data showed that a specific subset of CD11c^+^ cells are targets for free fatty acid--mediated increases in expression of proinflammatory cytokine.^[@bib19]^ We revealed that mice consuming high-fat diet showed significantly increased CD11c^+^ cells number in glomeruli and tubulointerstitium, which was substantially reduced in SR-A^−/−^ mice ([Figure 4a](#fig4){ref-type="fig"}). Using a flow cytometric analysis, we further found that both CD11c^+^/CD68^+^ and CD11c^−^/CD68^+^ cells increased in the kidneys of mice fed with high-fat diet; however, SR-A^−/−^ mice showed 60% reduction of CD11c^+^/CD68^+^ and 39.3% reduction of CD11c^−^/CD68^+^ cells compared with that of WT mice ([Figure 4b](#fig4){ref-type="fig"}). The difference in the reduced levels of the two subtype cells in ameliorated kidney implicated that CD11c^+^ macrophages are more important than resident macrophages in lipid-induced kidney injury. In addition, SR-A deficiency markedly reduced TNF-α and IL-6 levels in kidneys compared with that of WT mice in groups of high-fat diet ([Figure 4c--e](#fig4){ref-type="fig"}).

Several lines of study demonstrated that MCP-1 is a key mediator for inflammation.^[@bib20],\ [@bib21],\ [@bib22]^ Our data showed that WT mice consuming high-fat diet exhibited substantially increased MCP-1 in plasma and kidney, and this increase was suppressed in SR-A^−/−^ mice ([Table 1](#tbl1){ref-type="table"} and [Figure 4c](#fig4){ref-type="fig"}). To better understand the effect of SR-A on MCP-1 expression in high-fat diet mice, HK-2 cells, an immortalized proximal tubular epithelial cell line, were incubated with ox-LDL after forced expression or knockdown of SR-A. Consistent with these findings *in vivo*, forced expression of SR-A increased the lipids retention in HK-2 cells, and augmented the ox-LDL-stimulated ROS generation and MCP-1 expression; in contrast, knockdown of SR-A protected HK-2 cells from ox-LDL-stress ([Figure 5a--e](#fig5){ref-type="fig"}). To verify that the increased expression of MCP-1 was caused by ox-LDL-induced ROS, we examined MCP-1 in supernatant of cultured HK-2 cells pretreated with antioxidant manganese superoxide dismutase (MnSOD). Our data clearly showed that inhibition of ox-LDL-stimulated ROS markedly decreased the MCP-1 production in the condition of either normal or overexpression of SR-A ([Figure 5e](#fig5){ref-type="fig"}).

SR-A modulated TGF-β1/Smad signaling in tubular cells exposed to ox-LDL
-----------------------------------------------------------------------

Previous evidence has demonstrated a link between inflammatory environment and activation of TGF-β1/Smad signaling that contributes to pathological decline.^[@bib23],\ [@bib24],\ [@bib25],\ [@bib26]^ The current study showed that renal TGF-β1 was markedly increased in WT mice but was mild in SR-A^−/−^ mice fed with high-fat diet ([Figure 6a and b](#fig6){ref-type="fig"}). Upregulated TGF-β1 was confined largely to the area where fibrosis was evident. Coincident with the increased presence of TGF-β1, the percentage of phosphorylated Smad2/3 (p-Smad2/3)--positive nuclei was markedly increased in the kidneys of WT mice at 16 weeks of high-fat diet, and this increase was substantially reduced in SR-A^−/−^ mice ([Figure 6c and d](#fig6){ref-type="fig"}). These data demonstrated that ameliorated renal fibrosis in hyperlipidemic SR-A^−/−^ mice related to the inhibited renal TGF-β1/Smad signaling.

To further address that the renoprotective effect of SR-A deficiency is associated with the inhibited TGF-β1/Smad signaling, we stimulated HK-2 cells with ox-LDL after forced expression or knockdown of SR-A. As shown in [Figure 7a--d](#fig7){ref-type="fig"}, forced expressing SR-A enhanced TGF-β1 expression and Smad2/3 activation. Conversely, knockdown of SR-A inhibited TGF-β1 expression and Smad2/3 activation in HK-2 cells exposed to ox-LDL.

BM-derived leukocytes from SR-A^−/−^ mice decreased albuminuria and renal fibrosis in uninephrectomized mice fed with high-fat diet
-----------------------------------------------------------------------------------------------------------------------------------

To determine the contribution of SR-A from BM-derived leukocytes to lipid-induced kidney injury, we performed reciprocal BMT between WT and SR-A^−/−^ mice, using both as donors and recipients of BMT. Neither SR-A deficiency nor BMT affected the total number of peripheral blood erythrocyte and leukocyte counts or leukocyte differential ([Table 2](#tbl2){ref-type="table"}). All mice that did not receive BMT died within 3 weeks of the transplant. At 4 weeks after BMT, peripheral blood counts returned to normal and the mice underwent uninephrectomy, and were then randomized to either normal or high-fat diet for 16 weeks. Circulating leukocytes isolated from WT to WT and WT to SR-A^−/−^ BMT mice showed similar levels of SR-A expression compared with those of leukocytes from untransplanted WT mice, indicating successful BM replenishment ([Figure 8a](#fig8){ref-type="fig"}). Interestingly, SR-A^−/−^ to WT BMT mice showed less albumin/creatinine ratio and decreased glomerular mesangial matrix index and tubulointerstitial fibrosis area compared with those of WT to WT or WT to SR-A^−/−^ BMT mice ([Figure 8b--e](#fig8){ref-type="fig"}). Indeed, albumin/creatinine ratio, mesangial matrix index, and tubulointerstitial fibrosis area in WT to SR-A^−/−^ BMT mice were comparable to those of WT to WT BMT mice.

The role of BM-derived leukocyte SR-A in lipid-induced kidney injury was further evaluated at 16 weeks of high-fat diet in BMT mice. Renal content of cholesterol within kidney was markedly reduced in SR-A^−/−^ to WT BMT mice compared with that of WT to WT or WT to SR-A^−/−^ mice. Interestingly, the percentage of renal CD11c^+^ cells and CD68 macrophages in SR-A^−/−^ to WT BMT mice was substantially less than those of WT to WT or WT to SR-A^−/−^ BMT mice ([Figure 9b and c](#fig9){ref-type="fig"}). In addition, there were less MCP-1, TNF-α, and IL-6 expressed in kidney and that in plasma of SR-A^−/−^ to WT BMT mice compared with those of WT to SR-A^−/−^ or WT to WT BMT mice ([Figure 9d--f](#fig9){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}). These findings indicate that SR-A in circulating leukocytes rather than in renal resident cells is the predominant mediator in lipid-induced kidney injury.

DISCUSSION
==========

An emerging body of evidence suggests that hyperlipidemia is not only a risk factor for CKD progression, but also an independent inducer for renal dysfunction.^[@bib1],\ [@bib2]^ We now document in this study the profibrotic effects of SR-A on progressive renal fibrosis elicited by hyperlipidemia *in vivo* and *in vitro*. Our results indicate that SR-A is a key molecule to modulate the oxidative stress, inflammation, and fibrosis in the pathogenesis of hyperlipidemic CKD. Our finding suggests that SR-A deficiency protects mice from progressive nephropathy of hyperlipidemia through inhibiting of CD11c^+^ cell recruitment and TGF-β1/Smad pathway. Importantly, we validate the effectiveness of *in vivo* reconstitution with SR-A^−/−^ mice BM-derived leukocytes in lipid-induced nephropathy.

There is increasing evidence that ROS and other reactive species are directly involved in redox signaling pathways that promote inflammation. Our integrated *in vivo* and *in vitro* experimental design identified SR-A as a key modulator for tubular cells to uptake lipid. Consistent with previous studies,^[@bib8],\ [@bib18],\ [@bib27],\ [@bib28]^ our finding revealed that SR-A modulated ox-LDL-induced ROS generation in tubular cells, consequently stimulated the expression of MCP-1, which is a key mediator to recruit or activate inflammatory cells, and was also important in generating proinflammatory cytokine.^[@bib20],\ [@bib21],\ [@bib22]^

Another major finding of this study is that CD11c^+^ cell--specific SR-A is a primary inducer of renal injury in progressive nephropathy of hyperlipidemia. Emerging bodies of evidence have demonstrated a close association between the intensity of inflammation and the severity of renal fibrosis.^[@bib8],\ [@bib14],\ [@bib29],\ [@bib30]^ Indeed, the interstitial macrophages correlate closely with fibrosis.^[@bib6],\ [@bib15],\ [@bib31],\ [@bib32]^ Macrophages are phenotypically and functionally heterogeneous, potentially able to promote inflammation and fibrosis or to prevent it via scavenging activities.^[@bib10],\ [@bib30]^ Recently, a specific subset of CD11c^+^ macrophages was shown to be recruited to obese adipose and muscle tissue, and produced high levels of proinflammatory cytokines that were linked to the tissue injury. CD11c^+^ cell ablation led to a marked decrease in inflammatory markers locally and systemically.^[@bib19]^ Indeed, our data clearly showed that SR-A^−/−^ mice fed with high-fat diet demonstrated marked decrease in CD11c^+^ cells filtration and inflammatory markers expression in both kidneys and plasma. In chimeric study, SR-A^−/−^ to WT BMT led to reduced renal CD11c^+^ as well as CD68^+^ cells filtration, inflammatory cytokines expression, albuminuria, and renal fibrosis at 16 weeks of high-fat diet compared with those of WT to WT or WT to SR-A^−/−^ BMT mice. These findings indicate that SR-A on circulating leukocytes, such as CD11c^+^, rather than on resident cells is the predominant mediator of lipid-induced kidney injury. Although the markedly increased MCP-1 may be the key molecule to recruit CD11c^+^ in kidney, the precise mechanism by which SR-A modulates CD11c^+^ function is necessary to determine in the future study.

In addition to the oxidative stress and inflammatory profile, we revealed that SR-A modulates TGF-β1/Smad signaling. A wide array of studies has established that TGF-β1 modulates renal fibrosis through its downstream Smad signaling.^[@bib23],\ [@bib33],\ [@bib34]^ Indeed, our finding showed that deletion of SR-A significantly inhibited TGF-β1expression and thereby diminished phosphorylated Smad2/3 in the fibrotic kidneys. Furthermore, the current study provided the first evidence that forced expression of SR-A directly activates TGF-β1/Smad signaling in HK-2 cells exposed to ox-LDL *in vitro.* Therefore, inhibition of TGF-β1/Smad pathway in uninephrectomized SR-A^−/−^ mice with hyperlipidemia may be a mechanism whereby SR-A promotes renal fibrosis. These findings implicate that SR-A/TGF-β1/Smad pathway is a novel target in the treatment of renal fibrosis on hyperlipidemic mice model.

Taken together, our data allow us to establish that SR-A in tubular epithelial cells initiates lipid-induced oxidative stress and MCP-1 release, which leads to more circulating leukocytes recruited and promotes the renal fibrosis. Importantly, SR-A on circulating leukocytes rather than renal resident cells predominantly mediates lipid-induced kidney injury. These findings provide new insights into the role of SR-A in hyperlipidemic kidney injury and open a window of opportunity for a novel therapeutic intervention for the progression of CKD.

MATERIALS AND METHODS
=====================

Antibodies, plasmids, and other reagents
----------------------------------------

The antibodies and their sources are as follows: monoclonal anti-mouse CD11c and polyclonal anti-mouse SR-A were from BD Biosciences (Bedford, MA); monoclonal anti-mouse fibronectin, collagen I and III, TGF-β1, and polyclonal anti-mouse phosphoserine Smad2/3 and Smad2 were from Santa Cruz (Santa Cruz, CA); monoclonal anti-mouse β-actin was from Sigma-Aldrich (Buchs SG, Switzerland); and monoclonal anti-human TGF-β1, polyclonal anti-human phosphoserine Smad2/3, Smad2, SR-A, and monoclonal anti-mouse CD68 were from Abcam (Cambridge, MA).

SR-A small interfering RNA (siRNA; sc-44116) and nonspecific siRNA was purchased from Santa Cruz. pNVL3-MnSOD plasmid^[@bib35]^ was a kind gift from Dr Yewei Ma (Baylor College of Medicine, Houston, TX). The 3′-untranslated region of the *Homo sapiens macrophage scavenger receptor 1* (*MSR1*) gene (NM_138715) was amplified from HK-2 genomic DNA by PCR using the HotMaster Taq DNA polymerase (5 PRIME, Gaithersburg, MD), with the following primers: 5′-CATCAGGGATCCATGGAGCAGTGGGATCACTTTC-3′ (forward) and 5′-CATCAGGTTTAAACTTATAAAGTGCAAGTGACTCCAG-3′ (reverse). The 3763-bp PCR product was cloned between the *Pme*I and *Bam*HI site of the pCAG-GFP vector (Addgene plasmid 16664), to generate pCAG-SR-A.

Ox-LDL was a kind gift from Dr Jizhong Chen^[@bib36]^ (Baylor College of Medicine). Dihydrorhodamine-123 and dihydroethidium were purchased from Invitrogen (Carlsbad, CA); Creatinine Companion kit and urine albumin ELISA kit were purchased from Exocell (Philadelphia, PA); malondialdehyde TBARS Assay Kit was purchased from Cell Biolabs (San Diego, CA); RNeasy kit was purchased from Qiagen (Valencia, CA); MCP-1, TNF-α, and IL-6 ELISA kits were purchased from Phoenix Pharmaceuticals (Burlingame, CA); cholesterol CII kit and L-type triglyceride H kit were purchased from Wako Chemicals (Richmond, VA). All other reagents were purchased from Sigma-Aldrich unless otherwise noted.

Animal studies
--------------

SRA^−/−^ mice and their wild-type control have been described elsewhere.^[@bib13]^ To establish a lipid-induced kidney injury model, ∼20 g, male, 8-week-old WT and SRA^−/−^ mice underwent uninephrectomy, and were then randomized into four groups: *group 1*: WT, normal diet (standard chow containing 270 mg cholesterol per kg); *group 2*: SR-A^−/−^, normal diet; *group 3*: WT, high-fat diet (standard chow supplemented with 10% saturation oil and 1% cholesterol);^[@bib15],\ [@bib37]^ and *group 4*: SR-A^−/−^, high-fat diet; 12 animals in each group. Following 16 weeks of diet intervention, blood and kidneys were harvested for next experiment. All animal studies were carried out with the review and approval of the animal care and use committee of Sun Yat-sen University and Baylor College of Medicine.

Blood biochemical components and blood pressure analysis
--------------------------------------------------------

Plasma creatinine, MCP-1, TNF-α, IL-6, cholesterol, and triglyceride were measured using the kits described above according to the manufacturer\'s protocol. Systolic blood pressure was measured through a tail-cuff apparatus (AD Instruments, Bella Vista, Australia) in conscious mice. Systolic blood pressure values were derived from an average of five measurements per animal.

Morphometric studies
--------------------

With periodic acid--Schiff--stained sections, light microscopic views of 40 consecutive glomerular cross-sections per mouse were scanned into a computer. Glomerular and mesangial matrix area were quantified in a blinded fashion using an image analysis system (NIS Elements, Nikon, Sendai, Japan). Mesangial matrix index was calculated as the ratio of mesangial area to tuft area × 100 (% area). The percentage of tubulointerstitial fibrosis area was determined on Masson\'s trichrome-stained sections using a computer-aided manipulator program as described above. In all, 20 fields of tubulointerstitial area under low magnification ( × 200) per mouse were scanned to analyze the fibrosis area.

Oil Red O staining
------------------

Frozen sections were stained by Oil Red O and quantified as described with modification.^[@bib38]^ Briefly, Oil Red O--positive cells were counted in at least 20 high-power ( × 400) fields with a micro square scale plate (0.0625 mm^2^) arranged in ocular lens. The number of Oil Red O--positive cells in kidney was represented as cells/mm^2^.

Immunohistochemistry and immunoblot analysis
--------------------------------------------

Association of fibrosis protein was assessed by western blot and immunohistochemistry as described previously.^[@bib39],\ [@bib40]^

Lipid extraction and lipid peroxidation determination
-----------------------------------------------------

Total lipid was extracted from kidneys by the method of Bligh and Dyer.^[@bib41]^ Lipoperoxides in renal tissue were determined by measurement of malondiadehyde--thiobarbituric acid using a kit described above according to the manufacturer\'s protocol.

Determination of ROS
--------------------

Distribution of superoxide anion in kidney was stained by dihydroethidium (5 μmol/l) on frozen sections and the intensity was analyzed at 585 nm with a confocal microscopy. Quantification of superoxide anion in HK-2 cells was analyzed on the coverslips stained with dihydrorhodamine-123 (5 μmol/l). Fluorescence of the dihydrorhodamine-123 oxidation product was measured with a multi-channel analyzer using 490 nm excitation and recording the fluorescence emission at the optimum (525±3 nm).

Cell culture and plasmid, siRNA transfection
--------------------------------------------

HK-2 cells (human renal proximal tubular epithelial cells) were cultured as described.^[@bib42]^ Cells were grown to confluence and serum-deprived for 48 h before experimental manipulation. All experiments were performed under serum-free conditions. Under these conditions, the cells remained viable in a nonproliferation state. Nonspecific siRNA, SR-A siRNA, pCAG-SR-A, and pNVL3-MnSOD plasmid were transfected into HK-2 cells using Lipofectamine 2000TM (Invitrogen) at a final concentration of 30 nmol/l.

Flow cytometry
--------------

Mice renal cells were prepared as described.^[@bib43]^ The following primary monoclonal antibodies were used for labeling cell suspensions: monoclonal anti-CD11c (1:100), which recognizes the circulating cells, and monoclonal anti-CD68 (1:100), which recognize resident macrophages. Cells at a concentration of 5--10 × 10^6^ /ml were incubated with primary antibody in Hank\'s balanced salt solution with 1% fetal calf serum (HBSS-FCS) at 4 °C for 45 min. After three washes in HBSS-FCS, cells were resuspended at the same concentration and incubated with fluorescein-conjugated second antibody (Invitrogen) with 1% bovine serum albumin for 30 min at 4 °C. The cells were washed twice in HBSS-FCS and finally suspended at ∼1 × 10^6^ cells/ml in protein-free HBSS for flow cytometry (BD Biosciences) analysis.

BMT protocol
------------

Male WT C57BL/6 (The Jackson Laboratory, Sacramento, CA) and SR-A^−/−^ mice, 8 weeks old, underwent total body lethal irradiation (9.5 Gy) to eliminate endogenous BM stem cells and circulating leukocytes. BM cells used for repopulation were extracted from the femur and tibia of 12 WT and 12 SR-A^−/−^ mice. Irradiated mice were injected intravenously with 10^7^ BM cells from either WT or SR-A^−/−^ mice. At 4 weeks after BMT, blood and leukocyte counts returned to normal ([Table 2](#tbl2){ref-type="table"}). Therefore, uninephrectomized operation was performed 4 weeks after BMT. All irradiated mice that were not injected with transplanted BM cells died within 2 to 3 weeks after radiation.

Statistical analyses
--------------------

Data obtained from this study were expressed as the mean±s.e.m. Statistical analyses were performed using one-way analysis of variance followed by Tukey\'s multiple comparison test with GraphPad Prism 5.0 (GraphPad Software, San Diego, CA) to determine the significance of differences in multiple comparisons. A *P*-value of \<0.05 was considered statistically significant.
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![**Albuminuria and renal histology in uninephrectomized mice at 16 weeks of dietary intervention.** (**a**) Urinary albumin/creatinine tested at time points indicated. (**b**) Kidney weight, normalized for body weight. (**c**) Representative histological photomicrograph of glomeruli by periodic acid--Schiff staining. Scale bar=19 μm. (**d**) Bar graph summarizing the mesangial matrix index. (**e**) Representative histological photomicrograph of kidney by Masson\'s trichrome staining. Scale bar=19 μm. (**f**) Bar graph summarizing the percentage of tubulointerstitial fibrosis area. Each bar represented the mean±s.e.m., *n*=6--12 each group. SR-A, scavenger receptor A; SR-A^+/+^, SR-A wild-type mice; SR-A^−/−^, SR-A deficiency mice.](ki2011457f1){#fig1}

![**Renal extracellular matrix deposition in uninephrectomized mice at 16 weeks of dietary intervention.** (**a**) Representative western blot analyses of fibronectin, collagen I, and collagen III in whole kidney lysate. Densitometric analysis of (**b**) fibronectin, (**c**) collagen I, and (**d**) collagen III in western blot. Each bar represented the mean±s.e.m., *n*=3 each group. β-Actin was used as loading control. SR-A, scavenger receptor A; SR-A^+/+^, SR-A wild-type mice; SR-A^−/−^, SR-A deficiency mice.](ki2011457f2){#fig2}

![**Renal lipid accumulation and oxidative stress in uninephrectomized mice at 16 weeks of dietary intervention.** (**a**) Representative Oil Red O staining in the kidneys. Red, Oil Red O--positive cells; blue, hematoxylin counterstaining. Scale bar=19 μm. (**b**) Bar graph summarizing Oil Red--positive cells in the kidney. (**c**) Representative photomicrograph of super oxidative anion assessed by staining of dihydroethidium in the kidney. Scale bar=19 μm. (**d**) Bar graph summarizing dihydroethidium intensity in the kidney. (**e**) Correlation between dihydroethidium intensity and the renal cholesterol content in the kidney, *n*=24, *r*=0.9261, 95% confidence interval (CI) 0.8344--0.9679, *P*\<0.01. (**f**) Malondialdehyde level in the kidney of mice at 16 weeks of experiment. Each bar represented the mean±s.e.m., *n*=6 each group. SR-A, scavenger receptor A; SR-A^+/+^, SR-A wild-type mice; SR-A^−/−^, SR-A deficiency mice.](ki2011457f3){#fig3}

![**Filtration of CD11c^+^ cells and the proinflammatory markers in the kidney of uninephrectomized mice at 16 weeks of dietary intervention.** (**a**) Representative immunofluorescent staining of CD11c-positive cells in the kidney. Red, CD11c^+^ cells; blue, 4,6-diamidino-2-phenylindole (DAPI)-stained nuclei; scale bar=19 μm; G, glomeruli. (**b**) Representative flow cytometry analysis of CD11c^+^, CD68^+^, and CD11c^+^/CD68^+^ cells in the kidneys. The number in each field represented the mean percentage of the cell number from at least three independent experiments. FITC, fluorescein isothiocyanate. (**c**) Renal cytosolic MCP-1, (**d**) TNF-α, and (**e**) IL-6 assayed by enzyme-linked immunosorbent assay. Each bar represented the mean±s.e.m. for three independent experiments. IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; SR-A, scavenger receptor A; SR-A^+/+^, SR-A wild-type mice; SR-A^−/−^, SR-A deficiency mice; TNF-α, tumor necrosis factor-α.](ki2011457f4){#fig4}

![**Effects of SR-A on lipid uptake, oxidative stress, and MCP-1 expression in HK-2 cells exposed to ox-LDL.** (**a**) Representative Oil Red O staining of HK-2 cells incubated with ox-LDL (10 μmol/l). Red, Oil Red O--positive cells; blue, 4,6-diamidino-2-phenylindole (DAPI) counterstaining; scale bar=1 μm. (**b**) Bar graph summarizing the percentage of Oil Red O--positive cells (300 cells were counted in three independent experiments). (**c**) Representative cellular image of ROS stained by dihydrorhodamine-123 in HK-2 cells at 24 h after incubation with ox-LDL (10 μmol/l). Scale bar=1 μm. (**d**) Bar graph summarizing ROS in HK-2 cells. Each bar represented the mean±s.e.m. for three independent experiments. (**e**) MCP-1 levels in the supernatant analyzed by enzyme-linked immunosorbent assay. Each bar represented the mean±s.e.m. for three independent experiments. MCP-1, monocyte chemoattractant protein-1; MnSOD, manganese superoxide dismutase; ox-LDL, oxidative low-density lipoprotein; ROS, reactive oxygen species; si, small interfering; SR-A, scavenger receptor A.](ki2011457f5){#fig5}

![**TGF-β1/p-Smad2/3 expression in the kidney of uninephrectomized mice at 16 weeks of dietary intervention.** Representative immunohistochemistry image of (**a**) TGF-β1 and (**c**) p-Smad2/3 in the kidney. Quantification of (**b**) TGF-β1 and (**d**) phosphorylated Smad2/3 (p-Smad2/3) expressed in kidneys. Scale bar=19 μm. Each bar represents the mean±s.e.m. for at least six mice. SR-A, scavenger receptor A; SR-A^+/+^, SR-A wild-type mice; SR-A^−/−^, SR-A deficiency mice; TGF-β1, transforming growth factor-β1.](ki2011457f6){#fig6}

![**Effect of SR-A on TGF-β1/Smad signaling in HK-2 cells exposed to ox-LDL.** (**a**) Representative western blot analyses of SR-A, TGF-β1, Smad2, and phospho-Smad2/3 in HK-2 cells incubated with ox-LDL (10 μmol/l) for 24 h. Densitometric analysis of (**b**) SR-A, (**c**) TGF-β1, and (**d**) phosphorylated Smad2/3 (p-Smad2/3) in **a**. Each bar represents the mean±s.e.m. for at least three mice. β-Actin was used as a loading control. ox-LDL, oxidative low-density lipoprotein; si, small interfering; SR-A, scavenger receptor A; TGF-β1, transforming growth factor-β1.](ki2011457f7){#fig7}

![**Albuminuria and renal histology in BMT uninephrectomized mice at 16 weeks of dietary intervention.** (**a**) Representative western blot analyses of SR-A expression in circulating leukocytes. (**b**) Urinary albumin/creatinine. (**c**) Representative histological photomicrograph of kidney stained for glomerular mesangial matrix (periodic acid--Schiff stain). Scale bar=19 μm. (**d**) Bar graph summarizing the mesangial matrix index (MMI) in periodic acid--Schiff--stained section. (**e**) Bar graph summarizing the percentage of tubulointerstitial fibrosis area in trichrome-stained section. Each bar represents the mean±s.e.m. for at least six mice. BMT, bone marrow transplantation; SR-A, scavenger receptor A; SR-A^+/+^, SR-A wild-type mice; SR-A^−/−^, SR-A deficiency mice.](ki2011457f8){#fig8}

![**Renal lipid accumulation, leukocyte filtration, and cytokine expression in BMT uninephrectomized mice at 16 weeks of dietary intervention.** (**a**) Renal cholesterol content in the kidney. Percentage of (**b**) CD11c^+^ and (**c**) CD68^+^ cells in the kidneys analyzed by flow cytometry. (**d**) Renal cytosolic MCP-1, (**e**) TNF-α, and (**f**) IL-6 assayed by enzyme-linked immunosorbent assay. Each bar represented the mean±s.e.m. for at least six mice. BMT, bone marrow transplantation; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; SR-A, scavenger receptor A; SR-A^+/+^, SR-A wild-type mice; SR-A^−/−^, SR-A deficiency mice; TNF-α, tumor necrosis factor-α.](ki2011457f9){#fig9}

###### Metabolic data of four groups at 16 weeks of experiment

                                 **Normal diet**   **High-fat diet**                                           
  ------------------------------ ----------------- ------------------- --------------------------------------- ---------------------------------------
  Body weight (g)                34.6±1.5          35.2±1.6            55.2±1.8[a](#t1-fn2){ref-type="fn"}     54.5±1.7
  BP (mm Hg)                     92.0±11.2         91.1±8.9            94.2±10.3                               93.2±10.7
  Plasma Cr (μmol/l)             67.5±4.3          66.2±4.8            106.0±7.8[a](#t1-fn2){ref-type="fn"}    82.4±6.5[b](#t1-fn3){ref-type="fn"}
  Plasma triglyceride (mmol/l)   1.31±0.31         1.24±0.44           2.58±0.53[a](#t1-fn2){ref-type="fn"}    2.45±0.46
  Plasma cholesterol (mmol/l)    2.35±0.43         2.42±0.36           6.73±0.62[a](#t1-fn2){ref-type="fn"}    6.36±0.53
  Plasma MCP-1 (μg/l)            125.1±6.7         127.0±10.3          294.0±11.2[a](#t1-fn2){ref-type="fn"}   144.0±10.2[b](#t1-fn3){ref-type="fn"}
  Plasma IL-6 (μg/l)             109.43±6.3        111.28±9.5          445.3±15.6[a](#t1-fn2){ref-type="fn"}   169.4±8.7[b](#t1-fn3){ref-type="fn"}
  Plasma TNF-α (μg/l)            69.50±4.8         69.20±4.5           144.6±10.9[a](#t1-fn2){ref-type="fn"}   99.9±6.4[b](#t1-fn3){ref-type="fn"}

Abbreviations: BP, blood pressure; Cr, creatinine; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; SR-A, scavenger receptor A; SR-A^−/−^, SR-A deficiency mice; TNF-α, tumor necrosis factor-α WT, SR-A wild-type mice.

*P*\<0.05 versus WT mice fed with normal diet.

*P*\<0.05 versus WT mice fed high-fat diet.

Data are means±s.e.m.; *n*=12 in each group.

###### Peripheral blood counts on erythrocyte and leukocyte in mice at 4 weeks of BMT

                                      **Non-BMT mice**   **BMT mice**                             
  ----------------------------------- ------------------ -------------- ------------ ------------ ------------
  RBC number ( × 10^4^/mm^3^)         1115±73.5          1126±96.6      1184±110.8   1152±100.3   1239±121.4
  Leukocyte number ( × 10^2^/mm^3^)   21±2.01            20±2.14        21±1.47      20±1.68      22±1.97
  Lymphocyte (%)                      86.5±4.91          86.2±6.13      85.6±5.23    87.5±7.06    87.1±4.64
  Monocyte (%)                        3.4±0.38           3.5±0.26       4.0±0.25     3.5±0.65     4.1±0.32
  Neutrophil (%)                      9.4±0.65           9.5±1.12       9.7±0.95     9.8±1.64     9.8±1.79

Abbreviations: BMT, bone marrow transplantation; RBC, red blood cell number; SR-A, scavenger receptor A; SR-A^−/−^, SR-A deficiency mice; WT, SR-A wild-type mice.

Data are means±s.e.m.

###### Metabolic data of the BMT mice at 16 weeks of dietary intervention

                                 **Normal diet**   **High-fat diet**                                                                                               
  ------------------------------ ----------------- ------------------- ----------- --------------------------------------- --------------------------------------- ---------------------------------------------------------
  Body weight (g)                33.4±3.5          34.2±2.5            34.1±2.5    54.9±3.6[a](#t3-fn2){ref-type="fn"}     55.5±3.4[b](#t3-fn3){ref-type="fn"}     55.3±4.7[c](#t3-fn4){ref-type="fn"}
  BP (mm Hg)                     92.5±10.3         92.7±9.3            92.0±11.5   92.2±10.7                               94.2±10.8                               93.1±8.9
  Plasma Cr (mol/l)              62.5±5.3          66.5±6.4            63.5±4.7    110.4±6.5[a](#t3-fn2){ref-type="fn"}    106.0±7.8[b](#t3-fn3){ref-type="fn"}    96.2±8.5[c,d,e](#t3-fn4 t3-fn5 t3-fn6){ref-type="fn"}
  Plasma triglyceride (mmol/l)   1.33±0.56         1.41±0.61           1.35±0.36   2.55±0.41[a](#t3-fn2){ref-type="fn"}    2.58±0.63[b](#t3-fn3){ref-type="fn"}    2.54±0.94[c](#t3-fn4){ref-type="fn"}
  Plasma cholesterol (mmol/l)    2.45±0.48         2.39±0.63           2.49±0.46   6.76±0.93[a](#t3-fn2){ref-type="fn"}    6.79±0.69[b](#t3-fn3){ref-type="fn"}    6.72±0.76[c](#t3-fn4){ref-type="fn"}
  Plasma MCP-1 (μg/l)            129.1±9.2         126.1±8.7           128.9±9.7   279.0±10.2[a](#t3-fn2){ref-type="fn"}   264.0±11.2[b](#t3-fn3){ref-type="fn"}   167.0±10.3[c,d,e](#t3-fn4 t3-fn5 t3-fn6){ref-type="fn"}
  Plasma IL-6 (μg/l)             112.5±6.7         108.3±6.9           110.4±6.3   469.9±8.7[a](#t3-fn2){ref-type="fn"}    439.1±14.6[b](#t3-fn3){ref-type="fn"}   211.2±9.5[c,d,e](#t3-fn4 t3-fn5 t3-fn6){ref-type="fn"}
  Plasma TNF-α (μg/l)            73.5±6.9          69.0±7.8            68.5±7.1    159.9±6.8[a](#t3-fn2){ref-type="fn"}    174.6±10.1[b](#t3-fn3){ref-type="fn"}   99.20±14.6[c,d,e](#t3-fn4 t3-fn5 t3-fn6){ref-type="fn"}

Abbreviations: BMT, bone marrow transplantation; BP, blood pressure; Cr, creatinine; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; SR-A, scavenger receptor A; SR-A^−/−^, SR-A deficiency mice; TNF-α, tumor necrosis factor-α WT, SR-A wild-type mice.

*P*\<0.05 versus WT to WT BMT mice fed with normal diet.

*P*\<0.05 versus WT to SR-A^−/−^ BMT mice fed with normal diet.

*P*\<0.05 versus SR-A^−/−^ to WT BMT mice fed with normal diet.

*P*\<0.05 versus WT to WT BMT mice fed with high fat diet.

*P*\<0.05 versus WT to SR-A^−/−^ BMT mice fed with high-fat diet.

Data are means±s.e.m.

[^1]: These authors contributed equally to this work.
